Related Experiment Videos
[Plasmid pBR322 drug-resistance gene changes induced by glycidyl methacrylate]
1Institute of Basic Medical Sciences, Beijing.
Abstract:
A mutagen, glycidyl methacrylate (GMA), discovered by us a few years ago has been used to investigate the mutation mechanism of drug-resistance genes of plasmid pBR322. The results indicated that GMA binds strongly to pBR322 DNA, and this binding decreased the relative transformation efficiency using E. coli HB1O1 strain on LB plates containing ampicillin (Ap) or tetracycline (Tc). The mutants, ARpTSc, AspTRc and ASpTSc, have been isolated and their drug-resistance proved to be heritable.
Insights
Glycidyl methacrylate (GMA) is a mutagen that binds to plasmid pBR322 DNA, reducing bacterial transformation efficiency. Isolated mutants exhibit heritable drug resistance, offering insights into mutation mechanisms.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Context:
- Investigating the impact of mutagens on plasmid DNA.
- Understanding mechanisms of drug resistance in bacteria.
- Utilizing plasmid pBR322 as a model system.
Purpose:
- To elucidate the mutation mechanism of drug-resistance genes in plasmid pBR322 using glycidyl methacrylate (GMA).
- To analyze the binding interaction between GMA and pBR322 DNA.
- To characterize the resulting drug-resistant mutants.
Summary:
- Glycidyl methacrylate (GMA) was employed as a mutagen to study drug-resistance genes on plasmid pBR322.
- GMA demonstrated strong binding to pBR322 DNA, significantly decreasing transformation efficiency in E. coli HB101 on ampicillin and tetracycline plates.
- Heritable drug-resistant mutants (ARpTSc, AspTRc, ASpTSc) were successfully isolated and identified.
Impact:
- Provides a detailed mechanism of how GMA induces mutations in plasmid DNA.
- Contributes to understanding the genetic basis of antibiotic resistance.
- Offers potential applications in genetic engineering and the development of novel antimicrobial strategies.